How Much and From Whom?: An Exercise in Seed-Stage Financing
The founders of start-up biotech company Chiral Intermediates have an important decision to make. How much money to raise? When? And from what kinds of funding sources? This exercise walks through the market for chiral intermediates (a material that reduces harmful drug side effects), this new company's business model, and its quest for seed-stage financing.